Tiffany Eul Davis Inglis - 15 Oct 2025 Form 4 Insider Report for SERA PROGNOSTICS, INC. (SERA)

Signature
/s/ Benjamin G. Jackson, Attorney-in-fact
Issuer symbol
SERA
Transactions as of
15 Oct 2025
Net transactions value
$0
Form type
4
Filing time
15 Oct 2025, 19:12:12 UTC
Previous filing
15 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Inglis Tiffany Eul Davis Chief Medical Officer C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY /s/ Benjamin G. Jackson, Attorney-in-fact 15 Oct 2025 0002091798

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SERA Class A Common Stock Award $0 +75,000 $0.000000 75,000 15 Oct 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SERA Stock Option (right to buy) Award $0 +107,000 $0.000000 107,000 15 Oct 2025 Class A Common Stock 107,000 $3.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 25% of the original grant amount vests on the first anniversary of the vesting commencement date, which is October 10, 2025, and 1/12 of the remaining amount vests in quarterly installments for three years thereafter, subject to the Reporting Person continuing to provide services to the issuer.
F2 These stock options vest over four years as follows: 25% of the original grant amount vests on the first anniversary of the vesting commencement date, which is October 10, 2025, and 1/36 of the remaining amount vests in monthly installments for three years thereafter, subject to the Reporting Person continuing to provide services to the issuer.